Pharma
Vital Art and Science, developers of myVisionTrack, a vision test service for patients with age-related macular degeneration or diabetic eye disease, has received a second FDA clearance for their platform, which includes an app and a provider dashboard.
Cincinnati, Ohio-based MedaCheck, a company that sells a dedicated medication reminder tablet for seniors, has raised $1.
Pharma-focused mobile clinical trial data collection company Clinical Ink has merged with CentrosHealth, formerly MyHealthBook, which makes configurable mobile apps for clinical trial patient engagement.
San Francisco-based Glow, maker of digital health tools for women, integrated Walgreens' Prescription Refill API into its app so that Glow users can refill their birth control prescriptions directly from their Android or iOS app.
Less than a month after announcing its partnership with Novartis, Qualcomm is adding another big pharmaceutical company to its list of 2net partners: Roche, who will use Qualcomm Life's 2net platform to capture patient data from connected devices, starting with anti-coagulation meters.
Biogen Idec used Fitbit bands in a previous study
Biogen Idec has partnered with Google X, Google's business unit for long-term “moonshot” projects, to study outside factors that might contribute to the progression of multiple sclerosis (MS), according to a report from Bloomberg.
A recent study from San Francisco-based mscripts and retail pharmacy Avella Specialty Pharmacy found that mscripts mobile pharmacy app helped Avella's HIV patients to become more adherent to their medication.
Norwalk, Connecticut-based medication adherence platform company HealthPrize says it has succeeded in raising medication adherence an average of 54 percent across a series of pharma-sponsored pilot programs for various medical conditions, with sample sizes ranging from 250 to more than 7,000.
Qualcomm is already one of the biggest investors in digital health, according to Rock Health.